<root>
	<PMID Version="1">20051827</PMID>
	<Summary>
		1: Peng X, Li W, Tan G. Reversal of taxol resistance by cisplatin innasopharyngeal carcinoma by upregulating thromspondin-1 expression. AnticancerDrugs. 2010 Apr;21(4):381-8. doi: 10.1097/CAD.0b013e3283363980. PubMed PMID:20051827.
	</Summary>
	<MeshHeadingList>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000971">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002277">Carcinoma</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002945">Cisplatin</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D019008">Drug Resistance, Neoplasm</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D009303">Nasopharyngeal Neoplasms</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D017239">Paclitaxel</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D012097">Repressor Proteins</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015398">Signal Transduction</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D019700">Thrombospondin 1</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015854">Up-Regulation</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
	    </MeshHeading>
	</MeshHeadingList>
</root>
